BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹18 Cr | ₹18 Cr | ₹10 Cr | ₹6.17 Cr | ₹2.00 Cr |
What is the latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹10 Cr |
| Mar2022 | ₹6.17 Cr |
| Mar2021 | ₹2.00 Cr |
How is Contingent Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | -0.06 | |
| Mar2024 | ₹18 Cr | 67.43 | |
| Mar2023 | ₹10 Cr | 69.85 | |
| Mar2022 | ₹6.17 Cr | 208.45 | |
| Mar2021 | ₹2.00 Cr | - | |
Compare Contingent Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹385.1 Cr | 15.1% | 14.1% | 99.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,926.0 Cr | -3% | -1.9% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,062.0 Cr | -3.3% | -0.7% | -1.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,806.0 Cr | -3.8% | 2.8% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,910.0 Cr | -3% | 3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,755.0 Cr | -4.3% | -2% | 2.5% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 15.1% |
14.1% |
99.3% |
| SENSEX | -2% |
-3.8% |
-8.6% |
You may also like the below Video Courses